Evidence map›Paper›PMID 38500722›Full record

ArticleFrontiers in public health2024

Predictors of seasonal influenza and COVID-19 vaccination coverage among adults in Tennessee during the COVID-19 pandemic.

J Cunningham-Erves, W George, M Sanderson, E Stewart, S W Jin, J Davis, H M Brandt

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

J Cunningham-ErvesDepartment of Internal Medicine, School of Medicine, Meharry Medical College, Nashville, TN, United States.
W GeorgeDepartment of Health Policy, Vanderbilt University Medical Center, Nashville, TN, United States.
M SandersonDepartment of Family and Community Medicine, School of Medicine, Meharry Medical College, Nashville, TN, United States.
E StewartDepartment of Internal Medicine, School of Medicine, Meharry Medical College, Nashville, TN, United States.
S W JinSchool of Social Work, The University of Memphis, Memphis, TN, United States.
J DavisDepartment of Biochemistry and Cancer Biology, School of Medicine, Meharry Medical College, Nashville, TN, United States.
H M BrandtSt. Jude Children's Research Hospital, Department of Epidemiology and Cancer Control, Memphis, TN, United States.
Meharry Medical College · USSt. Jude Children's Research Hospital · USUniversity of Memphis · USVanderbilt University Medical Center · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Shondra Michelle Miller · 1985 to 2026
$166.9M
The RCMI Program in Health Disparities Research at Meharry Medical College - SupplementU54MD007586 · NIMHD · MEHARRY MEDICAL COLLEGE · PI SANIKA SAMUEL CHIRWA · 2017 to 2026
$48.2M
A tailored, health communication intervention for HPV vaccine hesitant familiesK01CA237748 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ERVES, JENNIFER C. · 2020 to 2023
$518k
NCI NIH HHS K01 CA237748NCI NIH HHS P30 CA021765NIMHD NIH HHS U54 MD007586
6 · The paper itself

Abstract

Background: The COVID-19 pandemic has convoluted hesitancy toward vaccines, including the seasonal influenza (flu) vaccine. Because of COVID-19, the flu season has become more complicated; therefore, it is important to understand all the factors influencing the uptake of these vaccines to inform intervention targets. This article assesses factors related to the uptake of influenza and COVID-19 vaccines among adults in Tennessee. Methods: A cross-sectional, secondary data analysis of 1,400 adults was conducted in Tennessee. The adult sample came from two data sources: Data source 1 completed a baseline survey from January to March 2022, and data source 2 was completed from May to August 2022. Data on vaccine attitudes, facilitators and barriers, and communication needs were collected via random digit dial by Scientific Telephone Samples (STS). Two multivariable logistic regression models were used to estimate adjusted odds ratios (aORs) and 95% confidence intervals (CIs) to predict sociodemographic and overall vaccine-related factors associated with receipt or non-receipt (referent) of COVID-19 and influenza vaccines. Results: Approximately 78% of the adult sample had received the COVID-19 vaccination. A significant positive association for COVID-19 vaccine uptake was seen among those who were older (aged 50-65) (aOR = 1.9; 95% CI: 1.2-3.2), Black (aOR = 2.0; 95% CI:1.3-2.8), and had a college education and higher (aOR = 2.3; 95% CI: 1.5-3.6). However, there was a significant negative association for persons reporting they were extremely religious (aOR = 0.5; 95% CI:0.3-0.9). Over 56% of the adult sample had received the influenza vaccination this season. Those who had a higher annual household income ($80,000+) (aOR = 1.9; 95% CI: 1.3-2.6) and had health insurance (aOR = 2.6; 95% CI: 1.4-4.8) had a significant positive association with influenza vaccine receipt. However, those who were employed part-time or were unemployed had a significant negative association for influenza vaccine receipt (aOR = 0.7; 95% CI: 0.5-0.9). Both COVID-19 and influenza vaccine receipt had strongly significant positive trends with increasing belief in effectiveness and trust ( Conclusion: Strategies to increase COVID-19 and influenza vaccination should be age-specific, focus on increasing geographical and financial access, and offer tailored messages to address concerns about these vaccines.

Indexed as

COVID-19Influenza, HumanInfluenza VaccinesAdultCOVID-19 VaccinesCross-Sectional StudiesHealth Knowledge, Attitudes, PracticeHumansPandemicsSeasonsTennesseeVaccinationVaccination CoverageCOVID-19 VaccinesInfluenza VaccinescoronavirusCOVID-19fluinfluenzaSARS-CoV-2vaccine uptake

Identifiers

PMID38500722
PMCPMC10945017
OpenAlexW4392372377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.